1) Cuesta MJ, Peralta V, Zarzuela A:Illness duration and neuropsychological impairments in schizophrenia. Schizophr Res 33:141-150, 1998
2) Ekerholm M, Firus WS, Faqerberg T, et al:Neurocognitive function in long-term treated schizophrenia:A five-year follow-up study. Psychiatry Res 200:144-152, 2012
3) Goldstein G, Beers SR, Shemansky WJ:Neuropsychological differences between schizophrenic patients with heterogeneous Wisconsin Card Sorting Test performance. Schizophr Res 21:13-18, 1996
4) Green MF, Kern RS, Braff DL, et al:Neurocognitive deficits and functional outcome in schizophrenia:Are we measuring the “right stuff” ? Schizophr Bull 26:119-136, 2000
5) Green MF, Nuechterlein KH, Gold JM, et al:Approaching a consensus cognitive battery for clinical trials in schizophrenia:The NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 56:301-307, 2004
6) Gur RC, Ragland JD, Moberg PJ, et al:Computerized neurocognitive scanning:II. The profile of schizophrenia. Neuropsyhopharmacology 25:777-788, 2001
7) Harvey PD, Howanitz E, Parrella M, et al:Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia:A comparison across treatment sites. Am J Psychiatry 155:1080-1086, 1998
8) 片桐秀晃,岡田剛,澤雅世,他:長期入院中の統合失調症患者における改訂長谷川式簡易知能評価スケールの経時的変化.精神科治療学 22:723-727, 2007
9) Kay SR, Opler LA, Fiszbein A Positive and Negative Syndrome Scale(PANSS)Rating Manual. Multi-Health System Inc, Tronto, 1991(山田寛,増井寛治,菊本弘次訳:陽性・陰性症状評価尺度(PANSS)マニュアル.星和書店,1991)
10) Keefe RS, Bilder RM, Harvey PD, et al:Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 31:2033-2046, 2006
11) Krishnadas R, Moore B, Nayak A, et al:Relationship of cognitive function in patients with schizophrenia in remission to disability:A cross-sectional study in an Indian sample. Ann Gen Psychiatry 6:19, 2007
12) Meier MH, Caspi A, Reichenberg A, et al:Neuropsychological decline in schizophrenia from the premorbid to the postonset period:Evidence from a population-representative longitudinal study. Am J Psychiatry 171:91-101, 2014
13) Midin M, Razali R, Zamzam R, et al:Clinical and cognitive correlates of employment among patients with schizophrenia:A cross-sectional study in Malaysia. Int J Ment Health Syst 5:14, 2011
14) Obayashi S, Matsushima E, Okubo Y, et al:Relationship between exploratory eye movements and clinical course in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 251:211-216, 2001
15) 緒方真一,山田達夫,本橋信夫,他:CogHealthの信頼性,妥当性,外挿可能性に関する検討.認知神経科学 10:119-129, 2008
16) 尾鷲登志美,岩波明,中込和幸,他:統合失調症における思考障害と遂行機能.臨床精神医学 36:897-905, 2007
17) Reichenberg A, Caspi A, Harrington H, et al:Static and dynamic cognitive deficits in childhood preceding adult schizophrenia:A 30-year study. Am J Psychiatry 167:160-169, 2010
18) Shamsi S, Lau A, Lencz T, et al:Cognitive and symptomatic predictors of functional disability in schizophrenia. Schizophr Res 126:257-264, 2011
19) Silverstein SM, Osborn LM, Palumbo DR:Rey-Osterrieth Complex Figure Test performance in acute, chronic, and remitted schizophrenia patients. J Clin Psychol 54:985-994, 1998
20) Suzuki M, Takahashi S, Matsushima E, et al:Exploratory eye movement dysfunction as a discriminator for schizophrenia:A large sample study using a newly developed digital computerized system. Eur Arch Psychiatry Clin Neurosci 259:186-194, 2009
21) Takahashi S, Tanabe E, Sakai T, et al:Relationship between exploratory eye movement, P300, and reaction time in schizophrenia. Psychiatry Clin Neurosci 62:396-403, 2008
22) Thompson W, Savla G, Vahia I, et al:Characterizing trajectories of cognitive functioning in older adults with schizophrenia:Does method matter? Schizophr Res143:90-96, 2013
23) Tregellas JR, Smucny J, Harris JG, et al:Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia. Am J Psychiatry 171:549-556, 2014